Table 1.
Baseline characteristics of patients with ASD with and without GERD
| Variable | Overall (n = 71) | GERD+ (n = 37) | GERD− (n = 34) | P value |
|---|---|---|---|---|
| Age (y) | 70.4 ± 7.4 | 70.8 ± 6.54 | 70.0 ± 8.23 | 0.6663 |
| Female/male gender (n) | 62/9 | 32/5 | 30/4 | 0.7297 |
| TK, standing (°) | 24.9 ± 19.0 | 29.3 ± 19.8 | 20.7 ± 17.3 | 0.0620 |
| TLK, standing (°) | 19.34 ± 18.4 | 23.7 ± 19.7 | 15.2 ± 16.1 | 0.0561 |
| LL, standing (°) | 13.2 ± 19.6 | 14.4 ± 18.2 | 12.2 ± 21.7 | 0.6571 |
| PI (°) | 53.1 ± 9.6 | 54.4 ± 11.2 | 51.9 ± 8.1 | 0.2963 |
| PT (°) | 37.5 ± 10.6 | 38.4 ± 10.0 | 36.5 ± 11.2 | 0.4759 |
| SS (°) | 17.0 ± 11.9 | 16.9 ± 10.1 | 17.2 ± 13.4 | 0.8947 |
| SVA (mm) | 104.8 ± 64.6 | 116.9 ± 56.8 | 93.1 ± 71.0 | 0.1354 |
| PI-LL(°) | 29.3 ± 16.5 | 27.52 ± 17.3 | 31.0 ± 15.4 | 0.3864 |
| Cobb angle (°) | 23.6 ± 16.9 | 26.9 ± 17.9 | 20.1 ± 15.1 | 0.0918 |
| TK, FBB (°) | 19.9 ± 15.8 | 24.2 ± 16.4 | 14.8 ± 13.6 | <0.05 |
| TLK, FBB (°) | 7.2 ± 14.4 | 13.6 ± 15.2 | −0.42 ± 8.8 | <0.0001 |
| LL, FBB (°) | 31.9 ± 16.3 | 29.9 ± 15.8 | 34.3 ± 17.0 | 0.0918 |
| Cobb angle ~30°/30°~ (n) | 22/15 | 29/5 | <0.05 | |
| Number of thoracolumbar vertebral fractures (n) | 0.55 ± 1.1 | 0.78 ± 1.3 | 0.32 ± 0.84 | 0.0876 |
| Intake of NSAIDs | 15 (21.1%) | 10 (27.02%) | 5 (14.7%) | 0.252 |
| Intake of bisphosphonates | 8 (11.3%) | 6 (16.2%) | 2 (5.88%) | 0.264 |
| Intake of PPI | 34 (47.9%) | 34 (91.9%) | 0 |
Data are mean ± standard deviation unless otherwise shown
Bolded values with P < 0.05
ASD adult spinal deformity, FBB fulcrum backward-bending, GERD gastroesophageal reflux disease, LL lumbar lordosis, TK thoracic kyphosis, TLK thoracolumbar kyphosis, PI pelvic incidence; PT pelvic tilt, SS sacral slope, SVA sagittal vertical axis, NSAIDs non-steroidal anti-inflammatory drugs, PPI Proton pump inhibitor